CD34 and neoplasm: Although some of studies reported the significant correlation of CD34 expression or BRAFV600E mutation in GNT with tumor recurrence or progression22, the extent of the surgical resection (or tumor location), instead of CD34 expression and BRAFV600E mutation, may play an important role of the tumor prognosis of low-grade GNT16,18,25,27.